- Home
- App Analytics
- DoseEase for Users
- DoseEase for Users Vs. cubeTMFm
DoseEase for Users vs cubeTMFm Uso e estatísticas
DoseEase manages and monitors the drug administration data of clinical trials on blockchain in real-time. Blockchain securely protects vital data from corruption, tampering, and losses, thus guaranteeing the Integrity of Clinical Trial data
- Apple App Store
- Gratuitos
- Saúde e fitness
Ranking da Loja
- -
cubeTMFm is a mobile app developed to provide smartphone access to cubeTMF® web services — CRScube’s trial master file (TMF) management solution for clinical trials.
App Features:
- Access and download TMF documents.
- eSign and QC documents per automated workflows.
- Upload document files using PDFs or images.
About the Web App:
cubeTMF® is CRScube’s web application for paperless trial master file (TMF) management. cubeTMF is fully scalable and exists securely on the cloud for global centralized access.
The system provides a simple, user-friendly interface and end-to-end features for constructing and managing a TMF repository as well as processing documents through automated eSign and QC workflows.
CRScube:
CRScube provides a comprehensive suite of eClinical solutions to CROs, Biotech, Pharmaceutical, Academic, and Non-Profit organizations globally. We are dedicated to providing the latest eClinical technology that is fast, flexible, and easy-to-use to streamline end-to-end operations for Phase I-IV, medical device, and Investigator-Initiated Trials.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
DoseEase for Users versus cubeTMFm comparação de classificação
Compare a tendência de classificação de DoseEase for Users nos últimos 28 dias versus cubeTMFm
Classificação
Nenhum dado disponível
Comparação da classificação de DoseEase for Users vs. cubeTMFm por país
Compare a tendência de classificação de DoseEase for Users nos últimos 28 dias versus cubeTMFm
Nenhum dado para exibir
Faça comparações com qualquer site com o nosso teste grátis
DoseEase for Users VS.
cubeTMFm
19ezembro d, 2024